Objective To evaluate the protective effect of antiidiopathic pulmonary fibrosis(IPF)marketed drug Pirfenidone and its clinical drug Sufenidone(SC1011)against lung injury in a mouse tuberculosis model.Methods C57BL/6 ...Objective To evaluate the protective effect of antiidiopathic pulmonary fibrosis(IPF)marketed drug Pirfenidone and its clinical drug Sufenidone(SC1011)against lung injury in a mouse tuberculosis model.Methods C57BL/6 mouse model of tuberculosis was established.A total of 75 C57BL/6 mice were infected with 1×10^(7) CFU/ml H37Rv suspension by aerosol and randomly divided into untreated(n=9)group.展开更多
Objective To compare the diagnostic performance of interferon gamma releasing assays(T-SPOT.TB)and adenosine deaminase(ADA)in pleural tuberculosis,and therefore to evaluate the value of T-SPOT.TB in a high tuberculosi...Objective To compare the diagnostic performance of interferon gamma releasing assays(T-SPOT.TB)and adenosine deaminase(ADA)in pleural tuberculosis,and therefore to evaluate the value of T-SPOT.TB in a high tuberculosis burden country.Methods From June 2011to November 2012,111 patients with pleural fluid in Beijing Chest Hospital,Capital Medical University展开更多
文摘Objective To evaluate the protective effect of antiidiopathic pulmonary fibrosis(IPF)marketed drug Pirfenidone and its clinical drug Sufenidone(SC1011)against lung injury in a mouse tuberculosis model.Methods C57BL/6 mouse model of tuberculosis was established.A total of 75 C57BL/6 mice were infected with 1×10^(7) CFU/ml H37Rv suspension by aerosol and randomly divided into untreated(n=9)group.
文摘Objective To compare the diagnostic performance of interferon gamma releasing assays(T-SPOT.TB)and adenosine deaminase(ADA)in pleural tuberculosis,and therefore to evaluate the value of T-SPOT.TB in a high tuberculosis burden country.Methods From June 2011to November 2012,111 patients with pleural fluid in Beijing Chest Hospital,Capital Medical University